Lactobacillus fermentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response

2014 ◽  
Vol 18 (1) ◽  
pp. 50-54 ◽  
Author(s):  
Jung-Min Yeo ◽  
Hyun-Jeong Lee ◽  
Jae-Won Kim ◽  
Joong-Bok Lee ◽  
Seung-Yong Park ◽  
...  
PLoS ONE ◽  
2010 ◽  
Vol 5 (10) ◽  
pp. e13099 ◽  
Author(s):  
Vidya A. Arankalle ◽  
Kavita S. Lole ◽  
Ravi P. Arya ◽  
Anuradha S. Tripathy ◽  
Ashwini Y. Ramdasi ◽  
...  

Viruses ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 379 ◽  
Author(s):  
Norbert J. Roberts

Human monocytes/macrophages play a central role in the immune response and defense of the host from influenza virus infection. They classically act as antigen-presenting cells for lymphocytes in the context of an immune cell cluster. In that setting, however, monocytes/macrophages exhibit additional, unexpected, roles. They are required for influenza virus infection of the lymphocytes in the cluster, and they are responsible for lymphocyte apoptosis via their synthesis and expression of the viral neuraminidase. Surprisingly, human alveolar macrophages, expected to be among the first cells to encounter the virus, are not susceptible to direct infection by a human influenza virus but can be infected when the virus is complexed with an antibody. Such monocyte/macrophage responses to influenza virus challenge should be considered part of a very complex but quite effective defense, since the common outcome is recovery of the host with development of immunity to the challenging strain of virus.


2014 ◽  
Vol 21 (5) ◽  
pp. 737-746 ◽  
Author(s):  
Christopher D. O'Donnell ◽  
Amber Wright ◽  
Leatrice Vogel ◽  
Kobporn Boonnak ◽  
John J. Treanor ◽  
...  

ABSTRACTThe hypothesis of original antigenic sin (OAS) states that the imprint established by an individual's first influenza virus infection governs the antibody response thereafter. Subsequent influenza virus infection results in an antibody response against the original infecting virus and an impaired immune response against the newer influenza virus. The purpose of our study was to seek evidence of OAS after infection or vaccination with the 2009 pandemic H1N1 (2009 pH1N1) virus in ferrets and humans previously infected with H1N1 viruses with various antigenic distances from the 2009 pH1N1 virus, including viruses from 1935 through 1999. In ferrets, seasonal H1N1 priming did not diminish the antibody response to infection or vaccination with the 2009 pH1N1 virus, nor did it diminish the T-cell response, indicating the absence of OAS in seasonal H1N1 virus-primed ferrets. Analysis of paired samples of human serum taken before and after vaccination with a monovalent inactivated 2009 pH1N1 vaccine showed a significantly greater-fold rise in the titer of antibody against the 2009 pH1N1 virus than against H1N1 viruses that circulated during the childhood of each subject. Thus, prior experience with H1N1 viruses did not result in an impairment of the antibody response against the 2009 pH1N1 vaccine. Our data from ferrets and humans suggest that prior exposure to H1N1 viruses did not impair the immune response against the 2009 pH1N1 virus.


2000 ◽  
Vol 164 (1) ◽  
pp. 79-85 ◽  
Author(s):  
Joanne M. Lumsden ◽  
Joanna M. Roberts ◽  
Nicola L. Harris ◽  
Robert J. Peach ◽  
Franca Ronchese

2017 ◽  
Vol 91 (23) ◽  
Author(s):  
Ericka Keef ◽  
Li Ang Zhang ◽  
David Swigon ◽  
Alisa Urbano ◽  
G. Bard Ermentrout ◽  
...  

ABSTRACT Immunosenescence, an age-related decline in immune function, is a major contributor to morbidity and mortality in the elderly. Older hosts exhibit a delayed onset of immunity and prolonged inflammation after an infection, leading to excess damage and a greater likelihood of death. Our study applies a rule-based model to infer which components of the immune response are most changed in an aged host. Two groups of BALB/c mice (aged 12 to 16 weeks and 72 to 76 weeks) were infected with 2 inocula: a survivable dose of 50 PFU and a lethal dose of 500 PFU. Data were measured at 10 points over 19 days in the sublethal case and at 6 points over 7 days in the lethal case, after which all mice had died. Data varied primarily in the onset of immunity, particularly the inflammatory response, which led to a 2-day delay in the clearance of the virus from older hosts in the sublethal cohort. We developed a Boolean model to describe the interactions between the virus and 21 immune components, including cells, chemokines, and cytokines, of innate and adaptive immunity. The model identifies distinct sets of rules for each age group by using Boolean operators to describe the complex series of interactions that activate and deactivate immune components. Our model accurately simulates the immune responses of mice of both ages and with both inocula included in the data (95% accurate for younger mice and 94% accurate for older mice) and shows distinct rule choices for the innate immunity arm of the model between younger and aging mice in response to influenza A virus infection. IMPORTANCE Influenza virus infection causes high morbidity and mortality rates every year, especially in the elderly. The elderly tend to have a delayed onset of many immune responses as well as prolonged inflammatory responses, leading to an overall weakened response to infection. Many of the details of immune mechanisms that change with age are currently not well understood. We present a rule-based model of the intrahost immune response to influenza virus infection. The model is fit to experimental data for young and old mice infected with influenza virus. We generated distinct sets of rules for each age group to capture the temporal differences seen in the immune responses of these mice. These rules describe a network of interactions leading to either clearance of the virus or death of the host, depending on the initial dosage of the virus. Our models clearly demonstrate differences in these two age groups, particularly in the innate immune responses.


2021 ◽  
Author(s):  
Liang Chen ◽  
Limei Zhu ◽  
Ying Qi

Abstract BackgroundThe Role of respiratory tract commensal bacteria in maintaining the immune homeostasis of the respiratory tract is not well eluciated. We aimed to analyze the effect of respiratory symbiotic bacteria on respiratory immune system and its immune response to exogenous pathogens.MethodsIn this study, SPF C57BL/6 male mice were sensitized by nasal drip of respiratory tract symbiotic bacteria s. aurcus for 6-8 weeks and then used to establish a s. aureus upper respiratory tract symbiosis mouse model. Subsequently, the mice were infected with influenza virus through nasal drip to establish a virus infection model. During the experiment, the immunopathological damage, cytokines and mechanisms related to immune response were analyzed and studied.ResultsThe study found that in the s.aureus upper respiratory tract symbiosis mouse model, s.aurcus sensitization significantly reduced the immune damage in the lungs caused by influenza virus A (IVA) infection, but this protective effect was significantly weakened when alveolar macrophages were cleared. Further studies found that during influenza virus infection, M2 alveolar macrophages (AM) secreted regulatory cytokines to suppress the excessive immune response induced by influenza virus infection. α7nAChR agonist GTS-21 could reduce inflammation in lung tissues, the amount of AM and the expression of inflammatory factors, and the secretion and expression of high-mobility group box 1 (HMGB1) in lung tissues, plasma and bronchoalveolar lavage fluid (BALF). GTS-21 also reduced the lung injury caused by IVA in mice and the levels of M1 type AM bioactive molecules inducible NO synthase (iNOS) and pro-inflammatory factors in AM, and increased the levels of M2 type AM bioactive molecules Arg1 and Ym1. Anti-HMGB 1 antibody reduced the inflammation of lung tissues of mice caused by IVA and inhibited the polarization of AM to M1. Recombinant HMGB1 (rHMGB1) increased the inflammation of lung tissues of mice caused by IVA and promoted the polarization of AM to M1.ConclusionsRespiratory commensal bacteria induced M2 alveolar macrophages with immunomodulatory function to protect the host against illness and death caused by IVA infection.


Sign in / Sign up

Export Citation Format

Share Document